These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19072936)

  • 21. [Impromidine-analogous guanidines: synthesis and activity at the histamine H2-receptor. 29. Histamine analogs].
    Elz S; Schunack W
    Arzneimittelforschung; 1988 Mar; 38(3):327-32. PubMed ID: 2898245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dimeric carbamoylguanidine-type histamine H2 receptor ligands: A new class of potent and selective agonists.
    Kagermeier N; Werner K; Keller M; Baumeister P; Bernhardt G; Seifert R; Buschauer A
    Bioorg Med Chem; 2015 Jul; 23(14):3957-69. PubMed ID: 25639885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and histamine H(3) and H(4) receptor activity of conformationally restricted cyanoguanidines related to UR-PI376.
    Geyer R; Buschauer A
    Arch Pharm (Weinheim); 2011 Dec; 344(12):775-85. PubMed ID: 21987304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct interaction of human and guinea pig histamine H2-receptor with guanidine-type agonists.
    Kelley MT; Bürckstümmer T; Wenzel-Seifert K; Dove S; Buschauer A; Seifert R
    Mol Pharmacol; 2001 Dec; 60(6):1210-25. PubMed ID: 11723228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-substituted piperidinyl alkyl imidazoles: discovery of methimepip as a potent and selective histamine H3 receptor agonist.
    Kitbunnadaj R; Hashimoto T; Poli E; Zuiderveld OP; Menozzi A; Hidaka R; de Esch IJ; Bakker RA; Menge WM; Yamatodani A; Coruzzi G; Timmerman H; Leurs R
    J Med Chem; 2005 Mar; 48(6):2100-7. PubMed ID: 15771452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A selective human H(4)-receptor agonist: (-)-2-cyano-1-methyl-3-[(2R,5R)-5- [1H-imidazol-4(5)-yl]tetrahydrofuran-2-y] methylguanidine.
    Hashimoto T; Harusawa S; Araki L; Zuiderveld OP; Smit MJ; Imazu T; Takashima S; Yamamoto Y; Sakamoto Y; Kurihara T; Leurs R; Bakker RA; Yamatodani A
    J Med Chem; 2003 Jul; 46(14):3162-5. PubMed ID: 12825954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacological activity of some new fluorescent small molecule histamine H2 receptor (H2-R) ligands, derived from aminopotentidine and squaramide, in the GTPase assay.
    Petrache G; Pavelescu MD
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(1):255-9. PubMed ID: 20509312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The expanded pharmacological profile of histamine H2 receptor (H2R) species isoforms with respect to the interaction with new squaramide H2R ligands, in the GTP-ASE assay.
    Petrache G; Pavelescu MD
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(3):915-20. PubMed ID: 20191855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of the N-terminus and the E2-loop onto the binding kinetics of the antagonist mepyramine and the partial agonist phenoprodifen to H(1)R.
    Wittmann HJ; Seifert R; Strasser A
    Biochem Pharmacol; 2011 Dec; 82(12):1910-8. PubMed ID: 21933664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-activity relationships of histamine H2-agonists, a new class of positive inotropic drugs.
    Buschauer A; Baumann G
    Agents Actions Suppl; 1991; 33():231-56. PubMed ID: 1828931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ligand-specific contribution of the N terminus and E2-loop to pharmacological properties of the histamine H1-receptor.
    Strasser A; Wittmann HJ; Seifert R
    J Pharmacol Exp Ther; 2008 Sep; 326(3):783-91. PubMed ID: 18577700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and evaluation of structurally constrained quinazolinone derivatives as potent and selective histamine H3 receptor inverse agonists.
    Nagase T; Mizutani T; Sekino E; Ishikawa S; Ito S; Mitobe Y; Miyamoto Y; Yoshimoto R; Tanaka T; Ishihara A; Takenaga N; Tokita S; Sato N
    J Med Chem; 2008 Nov; 51(21):6889-901. PubMed ID: 18841880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 4-(omega-(alkyloxy)alkyl)-1H-imidazole derivatives as histamine H(3) receptor antagonists/agonists.
    Meier G; Krause M; Hüls A; Ligneau X; Pertz HH; Arrang JM; Ganellin CR; Schwartz JC; Schunack W; Stark H
    J Med Chem; 2004 May; 47(10):2678-87. PubMed ID: 15115409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New activation model for the histamine H2 receptor, explaining the activity of the different classes of histamine H2 receptor agonists.
    Eriks JC; van der Goot H; Timmerman H
    Mol Pharmacol; 1993 Oct; 44(4):886-94. PubMed ID: 8232239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological differences between human and guinea pig histamine H1 receptors: Asn84 (2.61) as key residue within an additional binding pocket in the H1 receptor.
    Bruysters M; Jongejan A; Gillard M; van de Manakker F; Bakker RA; Chatelain P; Leurs R
    Mol Pharmacol; 2005 Apr; 67(4):1045-52. PubMed ID: 15626750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histamine H(4) receptor-RGS fusion proteins expressed in Sf9 insect cells: a sensitive and reliable approach for the functional characterization of histamine H(4) receptor ligands.
    Schneider EH; Seifert R
    Biochem Pharmacol; 2009 Sep; 78(6):607-16. PubMed ID: 19464266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of 4-(1H-imidazol-4(5)-ylmethyl)pyridine (immethridine) as a novel, potent, and highly selective histamine H(3) receptor agonist.
    Kitbunnadaj R; Zuiderveld OP; Christophe B; Hulscher S; Menge WM; Gelens E; Snip E; Bakker RA; Celanire S; Gillard M; Talaga P; Timmerman H; Leurs R
    J Med Chem; 2004 May; 47(10):2414-7. PubMed ID: 15115383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 4- or 5- (omega-aminoalkyl) thiazoles and derivatives; new selective H2-receptor agonists.
    Eriks JC; Sterk GJ; van der Aar EM; van Acker SA; van der Goot H; Timmerman H
    Agents Actions Suppl; 1991; 33():301-14. PubMed ID: 1828933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Side-chain modified analogues of histaprodifen: asymmetric synthesis and histamine H1-receptor activity.
    Patil R; Elz S; Reiser O
    Bioorg Med Chem Lett; 2006 Feb; 16(3):672-6. PubMed ID: 16266803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and in vitro pharmacology of arpromidine and related phenyl(pyridylalkyl)guanidines, a potential new class of positive inotropic drugs.
    Buschauer A
    J Med Chem; 1989 Aug; 32(8):1963-70. PubMed ID: 2569042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.